Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 07, 2019 at 04:31 pm EDT
Share
Medeon Biodesign, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 111.835 million compared to TWD 61.704 million a year ago. Operating loss was TWD 66.642 million compared to TWD 65.096 million a year ago. Net loss was TWD 55.984 million compared to TWD 25.521 million a year ago. Basic loss per share was TWD 0.84 compared to TWD 0.44 a year ago. For the half year, sales was TWD 206.427 million compared to TWD 529.851 million a year ago. Operating loss was TWD 127.285 million compared to operating Income of TWD 292.188 million a year ago. Net loss was TWD 108.708 million compared to net income of TWD 347.591 million a year ago. Basic loss per share was TWD 1.66 compared to basic earnings per share of TWD 6.08 a year ago. Diluted loss per share was TWD 1.66 compared to diluted earnings per share of TWD 6.01 a year ago.
Medeon Biodesign, Inc. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of medical equipment. The Company's main products include medical apparatus and instruments used in laparoscopic minimally invasive surgeries and cardiac catheter-related minimally invasive surgeries. The Company distributes its products in domestic market and to overseas markets.
MEDEON BIODESIGN, INC. 
